//
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) Trial
The Hospital Readmissions Reduction Program Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper
Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead?
HFpEF: From Mechanisms to Therapies
Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
3D Printing and Heart Failure: The Present and the Future
Heart Failure With Preserved Ejection Fraction in the Young